BNTC (Benitec Biopharma) Days Payable: 0.00 (As of Mar. 2026)


BNTC Benitec Biopharma Inc BNTC
34 GF Score
Price $12.45
View Full Analysis

What is Benitec Biopharma Days Payable?

Benitec Biopharma BNTC -4.16% 34 Days Payable is 0.00 as of Mar. 2026. GuruFocus rates BNTC with a GF Score™ of 34/100. Among 707 Biotechnology companies, Benitec Biopharma ranks worse than 141442.57% on this metric.

Benitec Biopharma's average Accounts Payable for the three months ended in Mar. 2026 was $0.83 Mil. Benitec Biopharma's Cost of Goods Sold for the three months ended in Mar. 2026 was $0.00 Mil.

The historical rank and industry rank for Benitec Biopharma's Days Payable or its related term are showing as below:

During the past 12 years, Benitec Biopharma's highest Days Payable was 14113.33. The lowest was 307.83. And the median was 811.05.

BNTC's Days Payable is not ranked *
in the Biotechnology industry.
Industry Median: 113.76
* Ranked among companies with meaningful Days Payable only.

Benitec Biopharma's Days Payable stayed the same from Mar. 2025 (0.00) to Mar. 2026 (0.00). stayed the same


Benitec Biopharma Days Payable Historical Data

* Premium members only.

The historical data trend for Benitec Biopharma's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Benitec Biopharma Days Payable Chart

Benitec Biopharma Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 824.96 14,113.33 0.00 0.00 0.00

Benitec Biopharma Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BNTC vs OABI, FBRX, LXEO: Days Payable Comparison

For the Biotechnology subindustry, Benitec Biopharma's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Benitec Biopharma Days Payable vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Benitec Biopharma's Days Payable distribution charts can be found below:

* The bar in red indicates where Benitec Biopharma's Days Payable falls into.


BNTC
34GF Score
Benitec Biopharma Inc BNTC
Days Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Benitec Biopharma Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Benitec Biopharma's Days Payable for the fiscal year that ended in Jun. 2025 is calculated as

Days Payable (A: Jun. 2025 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Jun. 2024 ) + Accounts Payable (A: Jun. 2025 )) / count ) / Cost of Goods Sold (A: Jun. 2025 )*Days in Period
=( (1.351 + 0.201) / 2 ) / 0*365
=0.776 / 0*365
=N/A

Benitec Biopharma's Days Payable for the quarter that ended in Mar. 2026 is calculated as:

Days Payable (Q: Mar. 2026 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Dec. 2025 ) + Accounts Payable (Q: Mar. 2026 )) / count ) / Cost of Goods Sold (Q: Mar. 2026 )*Days in Period
=( (1.016 + 0.635) / 2 ) / 0*365 / 4
=0.8255 / 0*365 / 4
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 0.00 mean?
Benitec Biopharma (BNTC) has a Days Payable of 0.00 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Benitec Biopharma and its competitors. Over the past decade, Benitec Biopharma's Days Payable has ranged from 307.83 to 14,113.33. According to the industry distribution chart, Benitec Biopharma ranks #999999 out of 707 companies in the Biotechnology industry.
Is Benitec Biopharma's Days Payable too high?
Benitec Biopharma's current Days Payable is 0.00. Over the past 10 years, this metric has ranged from a low of 307.83 to a high of 14,113.33. Based on the distribution chart, Benitec Biopharma ranks #999999 out of 707 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Benitec Biopharma has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Benitec Biopharma's Days Payable compare to OABI and FBRX?
According to the Biotechnology industry distribution chart, Benitec Biopharma ranks #999999 out of 707 companies for Days Payable. This places Benitec Biopharma in the lower half of its industry. The industry median Days Payable is 113.76. Historically, Benitec Biopharma's own Days Payable has ranged from 307.83 to 14,113.33 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 113.76, based on 707 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Benitec Biopharma and its competitors. For the Biotechnology industry, the median Days Payable is 113.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Benitec Biopharma's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Benitec Biopharma stock overvalued right now?
Benitec Biopharma (BNTC) has a current Days Payable of 0.00. The current Days Payable is 0.00. Benitec Biopharma's overall GF Score™ is 34/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Benitec Biopharma (BNTC), the current Days Payable is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Benitec Biopharma Business Description

Address 3940 Trust Way, Hayward, CA, USA, 94545
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
34GF Score

Get the complete analysis for BNTC

Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$12.45
Price